Pancreatic Cancer Research

ResearcherUniversity of Electronic Science and Technology of ChinaNo recent work listed

Jun Yan Gong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4635-1191; OpenAlex author ID A5000126150. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
2
Papers, trials and grants by year

2022: 1 paper

Papers 1

  1. CXCL12 secreted by pancreatic stellate cells accelerates gemcitabine resistance of pancreatic cancer by enhancing glycolytic reprogramming. Last author DOI 10.1080/19768354.2022.2091019↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao-jiong Yu · 1 shared paper, 2022 · strength 0.20
  2. Xiangyu Lu · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.